|
1
|
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.
|
Lancet Oncol
|
2012
|
5.70
|
|
2
|
Common variants at 19p13 are associated with susceptibility to ovarian cancer.
|
Nat Genet
|
2010
|
4.51
|
|
3
|
FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.
|
Cancer Cell
|
2009
|
4.48
|
|
4
|
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
|
Nat Genet
|
2009
|
4.38
|
|
5
|
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
|
Nat Genet
|
2013
|
4.35
|
|
6
|
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
|
Nat Genet
|
2010
|
3.86
|
|
7
|
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
|
JAMA
|
2012
|
3.85
|
|
8
|
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
|
Nat Genet
|
2013
|
3.42
|
|
9
|
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
|
Lancet Oncol
|
2013
|
2.48
|
|
10
|
Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders.
|
Blood
|
2007
|
2.25
|
|
11
|
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
|
Clin Cancer Res
|
2011
|
2.09
|
|
12
|
Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines.
|
Genome Res
|
2010
|
1.87
|
|
13
|
Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
|
Cancer Genet
|
2011
|
1.77
|
|
14
|
Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers.
|
PLoS One
|
2009
|
1.75
|
|
15
|
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation.
|
Nat Genet
|
2012
|
1.73
|
|
16
|
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
|
Nat Commun
|
2013
|
1.73
|
|
17
|
Assessment of genotype imputation methods.
|
BMC Proc
|
2009
|
1.68
|
|
18
|
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic.
|
Hypertension
|
2008
|
1.66
|
|
19
|
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.
|
Cancer Res
|
2011
|
1.64
|
|
20
|
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.
|
Gynecol Oncol
|
2013
|
1.61
|
|
21
|
Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients.
|
Clin Cancer Res
|
2011
|
1.47
|
|
22
|
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.
|
Endocr Relat Cancer
|
2013
|
1.47
|
|
23
|
Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer.
|
Oncology
|
2016
|
1.45
|
|
24
|
Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.
|
Cancer Res
|
2010
|
1.37
|
|
25
|
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
|
Nat Commun
|
2013
|
1.36
|
|
26
|
Inherited determinants of ovarian cancer survival.
|
Clin Cancer Res
|
2010
|
1.32
|
|
27
|
Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy.
|
Clin Cancer Res
|
2011
|
1.32
|
|
28
|
Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.22
|
|
29
|
PurBayes: estimating tumor cellularity and subclonality in next-generation sequencing data.
|
Bioinformatics
|
2013
|
1.20
|
|
30
|
Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology.
|
Neuro Oncol
|
2013
|
1.20
|
|
31
|
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers.
|
PLoS One
|
2011
|
1.20
|
|
32
|
Toll-like receptor polymorphisms and age-related macular degeneration.
|
Invest Ophthalmol Vis Sci
|
2008
|
1.18
|
|
33
|
Assessment of hepatocyte growth factor in ovarian cancer mortality.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.14
|
|
34
|
Acetaminophen-NAPQI hepatotoxicity: a cell line model system genome-wide association study.
|
Toxicol Sci
|
2010
|
1.11
|
|
35
|
Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.11
|
|
36
|
Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking.
|
Am J Epidemiol
|
2011
|
1.09
|
|
37
|
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.08
|
|
38
|
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies.
|
Cancer Causes Control
|
2013
|
1.03
|
|
39
|
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
1.02
|
|
40
|
Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration.
|
Invest Ophthalmol Vis Sci
|
2009
|
1.02
|
|
41
|
Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics.
|
Clin Cancer Res
|
2008
|
1.02
|
|
42
|
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.
|
Mol Endocrinol
|
2013
|
1.02
|
|
43
|
Use of the gamma method for self-contained gene-set analysis of SNP data.
|
Eur J Hum Genet
|
2011
|
1.01
|
|
44
|
Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.01
|
|
45
|
Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome.
|
Int J Mol Epidemiol Genet
|
2011
|
1.00
|
|
46
|
Familial aggregation of irritable bowel syndrome: a family case-control study.
|
Am J Gastroenterol
|
2010
|
0.99
|
|
47
|
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
|
Hum Genet
|
2013
|
0.99
|
|
48
|
Ovarian cancer risk associated with inherited inflammation-related variants.
|
Cancer Res
|
2012
|
0.98
|
|
49
|
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel.
|
Hum Mol Genet
|
2013
|
0.97
|
|
50
|
Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22.
|
Cancer Res
|
2010
|
0.96
|
|
51
|
Evaluation of clustering and genotype distribution for replication in genome wide association studies: the age-related eye disease study.
|
PLoS One
|
2008
|
0.95
|
|
52
|
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
|
BMC Cancer
|
2012
|
0.94
|
|
53
|
MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.94
|
|
54
|
Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22.
|
PLoS One
|
2012
|
0.93
|
|
55
|
No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer.
|
BMC Cancer
|
2009
|
0.93
|
|
56
|
Inherited variants in regulatory T cell genes and outcome of ovarian cancer.
|
PLoS One
|
2013
|
0.93
|
|
57
|
Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis.
|
Hepatology
|
2008
|
0.93
|
|
58
|
Genetic association studies of copy-number variation: should assignment of copy number states precede testing?
|
PLoS One
|
2012
|
0.93
|
|
59
|
Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer.
|
BMC Cancer
|
2009
|
0.93
|
|
60
|
Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene.
|
Gastroenterology
|
2008
|
0.92
|
|
61
|
Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.92
|
|
62
|
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.92
|
|
63
|
Genome-wide association analyses of genetic, phenotypic, and environmental risks in the age-related eye disease study.
|
Mol Vis
|
2010
|
0.91
|
|
64
|
FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder.
|
Pharmacogenet Genomics
|
2013
|
0.90
|
|
65
|
Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development.
|
BMC Med Genet
|
2011
|
0.90
|
|
66
|
Risk of ovarian cancer and inherited variants in relapse-associated genes.
|
PLoS One
|
2010
|
0.90
|
|
67
|
ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium.
|
Cancer Causes Control
|
2012
|
0.90
|
|
68
|
Comparison of Penalty Functions for Sparse Canonical Correlation Analysis.
|
Comput Stat Data Anal
|
2012
|
0.89
|
|
69
|
Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.
|
Cancer Res
|
2013
|
0.89
|
|
70
|
Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk.
|
Hum Genet
|
2014
|
0.89
|
|
71
|
Genome-wide gene-set analysis for identification of pathways associated with alcohol dependence.
|
Int J Neuropsychopharmacol
|
2012
|
0.89
|
|
72
|
Betaine-homocysteine methyltransferase: human liver genotype-phenotype correlation.
|
Mol Genet Metab
|
2010
|
0.89
|
|
73
|
Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism.
|
Pharmacogenet Genomics
|
2007
|
0.88
|
|
74
|
Identification of a novel percent mammographic density locus at 12q24.
|
Hum Mol Genet
|
2012
|
0.88
|
|
75
|
Identification of novel variants in colorectal cancer families by high-throughput exome sequencing.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.88
|
|
76
|
Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer.
|
Twin Res Hum Genet
|
2010
|
0.87
|
|
77
|
Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism.
|
Pharmacogenet Genomics
|
2008
|
0.86
|
|
78
|
Model selection and Bayesian methods in statistical genetics: summary of group 11 contributions to Genetic Analysis Workshop 15.
|
Genet Epidemiol
|
2007
|
0.86
|
|
79
|
Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk.
|
Mol Carcinog
|
2010
|
0.86
|
|
80
|
Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system.
|
Front Genet
|
2013
|
0.85
|
|
81
|
Comparison of tagging single-nucleotide polymorphism methods in association analyses.
|
BMC Proc
|
2007
|
0.84
|
|
82
|
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.84
|
|
83
|
Simultaneous analysis of multiple data types in pharmacogenomic studies using weighted sparse canonical correlation analysis.
|
OMICS
|
2012
|
0.84
|
|
84
|
Inflammation-related gene variants as risk factors for pancreatic cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.84
|
|
85
|
Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer.
|
Gynecol Oncol
|
2009
|
0.84
|
|
86
|
Mycophenolic acid response biomarkers: a cell line model system-based genome-wide screen.
|
Int Immunopharmacol
|
2011
|
0.83
|
|
87
|
Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.
|
Pharmacogenet Genomics
|
2012
|
0.83
|
|
88
|
Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes.
|
Pharmacogenomics
|
2014
|
0.83
|
|
89
|
Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.
|
Genet Epidemiol
|
2014
|
0.82
|
|
90
|
Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer.
|
Ann Surg
|
2013
|
0.82
|
|
91
|
Localization of association signal from risk and protective variants in sequencing studies.
|
Front Genet
|
2012
|
0.82
|
|
92
|
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.
|
Cancer Immunol Res
|
2014
|
0.82
|
|
93
|
Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer.
|
Pharmacogenomics
|
2014
|
0.82
|
|
94
|
Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines.
|
BMC Genomics
|
2014
|
0.81
|
|
95
|
Analysis of variation in NF-kappaB genes and expression levels of NF-kappaB-regulated molecules.
|
BMC Proc
|
2007
|
0.81
|
|
96
|
Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlation.
|
Drug Metab Dispos
|
2012
|
0.81
|
|
97
|
Ecto-5'-nucleotidase and thiopurine cellular circulation: association with cytotoxicity.
|
Drug Metab Dispos
|
2010
|
0.81
|
|
98
|
Common variation in Nemo-like kinase is associated with risk of ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.80
|
|
99
|
Genome-wide linkage analysis for uric acid in families enriched for hypertension.
|
Nephrol Dial Transplant
|
2009
|
0.79
|
|
100
|
Identifying the genetic variation of gene expression using gene sets: application of novel gene Set eQTL approach to PharmGKB and KEGG.
|
PLoS One
|
2012
|
0.79
|
|
101
|
SSBP2 variants are associated with survival in glioblastoma patients.
|
Clin Cancer Res
|
2012
|
0.79
|
|
102
|
Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort.
|
Fertil Steril
|
2010
|
0.79
|
|
103
|
The genetics of gene expression: comparison of linkage scans using two phenotype normalization methods.
|
BMC Proc
|
2007
|
0.79
|
|
104
|
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.
|
PLoS One
|
2011
|
0.78
|
|
105
|
Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release.
|
Physiol Genomics
|
2008
|
0.78
|
|
106
|
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.
|
Mol Nutr Food Res
|
2014
|
0.77
|
|
107
|
Methods for analysis in pharmacogenomics: lessons from the Pharmacogenetics Research Network Analysis Group.
|
Pharmacogenomics
|
2009
|
0.77
|
|
108
|
European American stratification in ovarian cancer case control data: the utility of genome-wide data for inferring ancestry.
|
PLoS One
|
2012
|
0.76
|
|
109
|
Density of common complex ocular traits in the aging eye: analysis of secondary traits in genome-wide association studies.
|
PLoS One
|
2008
|
0.76
|
|
110
|
Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma.
|
PLoS One
|
2013
|
0.76
|
|
111
|
Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma.
|
Front Genet
|
2012
|
0.76
|
|
112
|
Participation bias and its impact on the assembly of a genetic specimen repository for a myocardial infarction cohort.
|
Mayo Clin Proc
|
2007
|
0.76
|
|
113
|
Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.75
|
|
114
|
Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci.
|
Am J Epidemiol
|
2016
|
0.75
|
|
115
|
Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer.
|
Nat Genet
|
2015
|
0.75
|
|
116
|
Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer.
|
Pharmacogenet Genomics
|
2016
|
0.75
|
|
117
|
Association of TNFSF8 polymorphisms with peripheral neutrophil count.
|
Mayo Clin Proc
|
2011
|
0.75
|
|
118
|
Linkage analysis using principal components of gene expression data.
|
BMC Proc
|
2007
|
0.75
|
|
119
|
Bayseian genomic models for the incorporation of pathway topology knowledge into association studies.
|
Stat Appl Genet Mol Biol
|
2013
|
0.75
|
|
120
|
Comparison of variable and model selection methods for genetic association studies using the GAW15 simulated data.
|
BMC Proc
|
2007
|
0.75
|